financetom
Business
financetom
/
Business
/
Update: Market Chatter: UnitedHealth Shares Fall on Ackman Post Questioning Profitability
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: UnitedHealth Shares Fall on Ackman Post Questioning Profitability
Feb 5, 2025 8:40 AM

11:12 AM EST, 02/05/2025 (MT Newswires) -- (Updates with UnitedHealth's ( UNH ) response to Ackman's social media post.)

UnitedHealth Group ( UNH ) shares declined on Wednesday following a now-deleted post from investor Bill Ackman on X, saying that he would short the health insurer's stock, while questioning the company's profitability, according to Bloomberg.

Ackman, the founder of Pershing Square Capital, said he would not be surprised to find that the insurer's profitability is "massively overstated" due to its denial of medically necessary procedures and patient care, Bloomberg reported.

"Health insurance has long been subject to significant regulatory oversight and earnings caps," UnitedHealth ( UNH ) said in a statement posted on its website. "Any claims that health insurers, which typically have low- to mid-single digit margins, can somehow over-earn are grossly uninformed about the structure and strong regulatory oversight of the sector."

UnitedHealth ( UNH ) shares were down 2.3% in recent trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 534.50, Change: -10.95, Percent Change: -2.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck Initiates Phase 3 Trial of Zilovertamab Vedotin Antibody-Drug Conjugate to Treat Lymphoma
Merck Initiates Phase 3 Trial of Zilovertamab Vedotin Antibody-Drug Conjugate to Treat Lymphoma
Feb 6, 2025
09:04 AM EST, 02/06/2025 (MT Newswires) -- Merck ( MRK ) said Thursday that it has initiated a pivotal phase 3 clinical trial evaluating zilovertamab vedotin, an investigational antibody-drug conjugate to treat patients with previously untreated diffuse large B-cell lymphoma. The company said the trial will combine zilovertamab vedotin with rituximab plus cyclophosphamide, doxorubicin and prednisone, compared with rituximab plus...
Pop-Tarts maker Kellanova beats quarterly sales, profit estimates on steady demand
Pop-Tarts maker Kellanova beats quarterly sales, profit estimates on steady demand
Feb 6, 2025
Feb 6 (Reuters) - Packaged food company Kellanova ( K ) beat Wall Street expectations for fourth-quarter earnings on Thursday, on the back of steady demand for its snacks and breakfast cereals such as Pringles and Cheez-It. While other packaged food companies such as Conagra and McCormick ( MKC ) are facing a demand slowdown as customers cut back on...
Sonos Fiscal Q1 Non-GAAP Net Income, Revenue Decrease
Sonos Fiscal Q1 Non-GAAP Net Income, Revenue Decrease
Feb 6, 2025
09:04 AM EST, 02/06/2025 (MT Newswires) -- Sonos ( SONO ) reported fiscal Q1 non-GAAP net income Thursday of $0.64 per diluted share, down from $0.84 a year earlier. Three analysts polled by FactSet expected $0.30. Revenue for the fiscal quarter ended Dec. 28 was $550.9 million, down from $612.9 million a year earlier. Analysts surveyed by FactSet expected $519.8...
Ride-hailing platform Lyft ties up with Anthropic for AI-powered customer care
Ride-hailing platform Lyft ties up with Anthropic for AI-powered customer care
Feb 6, 2025
Feb 6 (Reuters) - Lyft ( LYFT ) said on Thursday it has tied up with Amazon ( AMZN ) and Alphabet-backed startup Anthropic to roll out artificial intelligence tools for the ride-hailing platform's customer care operations. The company said it has been using Anthropic's Claude AI model, through Amazon's ( AMZN ) Bedrock generative AI platform, which has helped...
Copyright 2023-2026 - www.financetom.com All Rights Reserved